Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983

DNA sequencing with chain-terminating inhibitors

Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572

A comprehensive set of sequence analysis programs for the VAX

Devereux, J., Haeberli, P. E., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

Wiley, D. C., Wilson, I. A., & Skehel, J. J. (1981) · Nature · doi:10.1038/289373a0 · Cited by 1,623

THE STRUCTURE AND FUNCTION OF THE HEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF INFLUENZA VIRUS

Wiley, D. C., & Skehel, J. J. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.002053 · Cited by 1,413

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

Caton, A. J., Brownlee, G. G., Yewdell, J. W., & Gerhard, W. (1982) · Cell · doi:10.1016/0092-8674(82)90135-0 · Cited by 1,036

Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites

Both, G. W., Sleigh, M. J., Cox, N. J., & Kendal, A. P. (1983) · Journal of Virology · doi:10.1128/jvi.48.1.52-60.1983 · Cited by 327

Geographic distribution of wild poliovirus type 1 genotypes

Rico-Hesse, R., Pallansch, M. A., Nottay, B. K., & Kew, O. M. (1987) · Virology · doi:10.1016/0042-6822(87)90001-8 · Cited by 327

Evidence for host-cell selection of influenza virus antigenic variants

Schild, G. C., OXFORD, J. S., de Jong, J. C., & Webster, R. G. (1983) · Nature · doi:10.1038/303706a0 · Cited by 314

Evolution of Human Influenza A Viruses Over 50 Years: Rapid, Uniform Rate of Change in NS Gene

Buonagurio, D. A., Nakada, S., Parvin, J. D., Krystal, M., Palese, P., & Fitch, W. M. (1986) · Science · doi:10.1126/science.2939560 · Cited by 288

Differences in RNA patterns of influenza A viruses

Palese, P., & Schulman, J. L. (1976) · Journal of Virology · doi:10.1128/jvi.17.3.876-884.1976 · Cited by 223

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2018–19 Influenza Season

Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,640

Highly Conserved Protective Epitopes on Influenza B Viruses

Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V., Jongeneelen, M. A. C., et al. (2012) · Science · doi:10.1126/science.1222908 · Cited by 857

Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution

Koel, B. F., Burke, D. F., Bestebroer, T. M., van der Vliet, S., Zondag, G. C. M., Vervaet, G., Skepner, E., Lewis, N. S., Spronken, M. I. J., Russell, C. A., et al. (2013) · Science · doi:10.1126/science.1244730 · Cited by 634

Prevention and Control of Seasonal Influenza with Vaccines

Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. (2016) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 602

Influenza A Virus Cell Entry, Replication, Virion Assembly and Movement

Dou, D., Revol, R., Østbye, H., Wang, H., & Daniels, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01581 · Cited by 621

Influenza virus-induced lung injury: pathogenesis and implications for treatment

Herold, S., Becker, C., Ridge, K. M., & Budinger, G. R. S. (2015) · European Respiratory Journal · doi:10.1183/09031936.00186214 · Cited by 517

The evolution of human influenza viruses

Hay, A. J., Gregory, V., Douglas, A., & Lin, Y. P. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2001.0999 · Cited by 493

Influenza Virus: Dealing with a Drifting and Shifting Pathogen

Kim, H., Webster, R. G., & Webby, R. J. (2018) · Viral Immunology · doi:10.1089/vim.2017.0141 · Cited by 423

Integrating influenza antigenic dynamics with molecular evolution

Bedford, T., Suchard, M. A., Lemey, P., Dudas, G., Gregory, V., Hay, A. J., McCauley, J. W., Russell, C. A., Smith, D. J., & Rambaut, A. (2014) · eLife · doi:10.7554/elife.01914 · Cited by 401

Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.

Grohskopf, L. A., Shay, D. K., Shimabukuro, T. T., Sokolow, L. Z., Keitel, W. A., Bresee, J., & Cox, N. J. (2013) · PubMed · Cited by 471

Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis

Tricco, A. C., Chit, A., Soobiah, C., Hallett, D. C., Meier, G., Chen, M. H., Tashkandi, M. F., Bauch, C. T., & Loeb, M. B. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-153 · Cited by 399

The rationale for quadrivalent influenza vaccines

Ambrose, C. S., & Levin, M. J. (2012) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.8.1.17623 · Cited by 375

The Burden of Influenza B: A Structured Literature Review

Glezen, W. P., Schmier, J. K., Kuehn, C. M., Ryan, K. J., & OXFORD, J. S. (2013) · American Journal of Public Health · doi:10.2105/ajph.2012.301137 · Cited by 365

Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines

Ohmit, S. E., Victor, J. C., Rotthoff, J. R., Teich, E., Truscon, R., Baum, L. L., Rangarajan, B., Newton, D. W., Boulton, M. L., & Monto, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061850 · Cited by 295

Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines

Monto, A. S., Ohmit, S. E., Petrie, J. G., Johnson, E., Truscon, R., Teich, E., Rotthoff, J. R., Boulton, M. L., & Victor, J. C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808652 · Cited by 277

From Original Antigenic Sin to the Universal Influenza Virus Vaccine

Henry, C., Palm, A.-K. E., Krammer, F., & Wilson, P. C. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.08.003 · Cited by 262

The Evolutionary Dynamics of Human Influenza B Virus

Chen, R., & Holmes, E. C. (2008) · Journal of Molecular Evolution · doi:10.1007/s00239-008-9119-z · Cited by 261

Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination

Vijaykrishna, D., Sullivan, S. G., Edwards, K. M., Xie, R., Khvorov, A., Valkenburg, S. A., Cowling, B. J., & Barr, I. (2022) · Nature Communications · doi:10.1038/s41467-022-29402-5 · Cited by 258

The contrasting phylodynamics of human influenza B viruses

Vijaykrishna, D., Holmes, E. C., Joseph, U., Fourment, M., Su, Y. C. F., Halpin, R., Lee, R. T., Deng, Y., Gunalan, V., Lin, X., et al. (2015) · eLife · doi:10.7554/elife.05055 · Cited by 231

Serologic assays for influenza surveillance, diagnosis and vaccine evaluation

Katz, J. M., Hancock, K., & Xu, X. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.51 · Cited by 236

The Mechanism behind Influenza Virus Cytokine Storm

Gu, Y., Zuo, X., Zhang, S., Ouyang, Z., Jiang, S., Wang, F., & Wang, G. (2021) · Viruses · doi:10.3390/v13071362 · Cited by 241

The evolving history of influenza viruses and influenza vaccines

HANNOUN, C. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.824709 · Cited by 216

Towards a universal influenza vaccine: different approaches for one goal

Sautto, G. A., Kirchenbaum, G. A., & Ross, T. M. (2018) · Virology Journal · doi:10.1186/s12985-017-0918-y · Cited by 202

Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein

Garcia, O. S. R., Martin, M. J., Dopazo, J., Arbiza, J., Frabasile, S., Russi, J., Hortal, M., Pérez‐Breña, P., Martínez, I., & García‐Barreno, B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5448-5459.1994 · Cited by 199

The need for quadrivalent vaccine against seasonal influenza

Belshe, R. B. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.028 · Cited by 193

Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands

Bodewes, R., de Mutsert, G., van der Klis, F. R. M., Ventresca, M., Wilks, S., Smith, D. J., Koopmans, M., Fouchier, R. A. M., Osterhaus, A. D. M. E., & Rimmelzwaan, G. F. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00396-10 · Cited by 186

Reassortment and Insertion-Deletion Are Strategies for the Evolution of Influenza B Viruses in Nature

McCullers, J. A., Wang, G. C., He, S., & Webster, R. G. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7343-7348.1999 · Cited by 180

The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century

Caini, S., Kusznierz, G. F., Garate, M. V. V., Wangchuk, S., Thapa, B., Júnior, F. J. D. P., de Almeida, W. A. F., Njouom, R., Fasce, R., Bustos, P., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222381 · Cited by 179

Myocardial Injury and Bacterial Pneumonia Contribute to the Pathogenesis of Fatal Influenza B Virus Infection

Paddock, C. D., Liu, L., Denison, A. M., Bartlett, J. H., Holman, R. C., DeLeon-Carnes, M., Emery, S. L., Drew, C. P., Shieh, W.-J., Uyeki, T. M., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir861 · Cited by 171

TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes

Limburg, H., Harbig, A., Bestle, D., Stein, D. A., Moulton, H. M., Jaeger, J., Janga, H., Hardes, K., Koepke, J., Schulte, L. N., et al. (2019) · Journal of Virology · doi:10.1128/jvi.00649-19 · Cited by 171

Reappearance and Global Spread of Variants of Influenza B/Victoria/2/87 Lineage Viruses in the 2000–2001 and 2001–2002 Seasons

Shaw, M. W., Xu, X., Li, Y., Normand, S., Ueki, R., Kunimoto, G. Y., Hall, H. E., Klimov, A. I., Cox, N. J., & Subbarao, K. (2002) · Virology · doi:10.1006/viro.2002.1719 · Cited by 171

Blue Journal Conference. Aging and Susceptibility to Lung Disease

Thannickal, V. J., Murthy, M., Balch, W. E., Chandel, N. S., Meiners, S., Eickelberg, O., Selman, M., Pardo, A., White, E. S., Levy, B. D., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201410-1876pp · Cited by 165

Rescue of influenza B virus from eight plasmids

Hoffmann, E., Mahmood, K., Yang, C., Webster, R. G., Greenberg, H. B., & Kemble, G. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393399 · Cited by 157

Biosensors for the detection of respiratory viruses: A review

Ribeiro, B. V., Cordeiro, T. A. R., Freitas, G. R. O. E., Ferreira, L. F., & Franco, D. L. (2020) · Talanta Open · doi:10.1016/j.talo.2020.100007 · Cited by 155

Crystal Structure of Unliganded Influenza B Virus Hemagglutinin

Wang, Q., Cheng, F., Lu, M., Xia, T., & Ma, J. (2008) · Journal of Virology · doi:10.1128/jvi.02477-07 · Cited by 154

Broadly neutralizing antibodies against influenza viruses

Laursen, N. S., & Wilson, I. A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.021 · Cited by 153

Impact of Influenza B Lineage-Level Mismatch Between Trivalent Seasonal Influenza Vaccines and Circulating Viruses, 1999–2012

Heikkinen, T., Ikonen, N., & Ziegler, T. T. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu664 · Cited by 151

Multiple Genotypes of Influenza B Virus Circulated between 1979 and 2003

McCullers, J. A., Saito, T., & Iverson, A. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.12817-12828.2004 · Cited by 144

A plant-derived quadrivalent virus like particle influenza vaccine induces cross-reactive antibody and T cell response in healthy adults

Pillet, S., Aubin, É., Trépanier, S., Bussière, D., Dargis, M., Poulin, J., Yassine‐Diab, B., Ward, B. J., & Landry, N. (2016) · Clinical Immunology · doi:10.1016/j.clim.2016.03.008 · Cited by 146

Better influenza vaccines: an industry perspective

Chen, J.-R., Liu, Y.-M., Tseng, Y.-C., & Ma, C. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-0626-6 · Cited by 143

Secretory IgA antibodies provide cross‐protection against infection with different strains of influenza B virus

Asahi‐Ozaki, Y., Yoshikawa, T., Iwakura, Y., Suzuki, Y., Tamura, S., Kurata, T., & Sata, T. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20173 · Cited by 141

Tackling influenza with broadly neutralizing antibodies

Corti, D., Cameroni, E., Guarino, B., Kallewaard, N. L., Zhu, Q., & Lanzavecchia, A. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.03.002 · Cited by 133

Comparative Analysis of Evolutionary Mechanisms of the Hemagglutinin and Three Internal Protein Genes of Influenza B Virus: Multiple Cocirculating Lineages and Frequent Reassortment of the NP, M, and NS Genes

Lindstrom, S., Hiromoto, Y., Nishimura, H., Saito, T., Nerome, R., & Nerome, K. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4413-4426.1999 · Cited by 131

Molecular Evolution and Circulation Patterns of Human Respiratory Syncytial Virus Subgroup A: Positively Selected Sites in the Attachment G Glycoprotein

Zlateva, K. T., Lemey, P., Vandamme, A., & Ranst, M. A. V. (2004) · Journal of Virology · doi:10.1128/jvi.78.9.4675-4683.2004 · Cited by 130

Knowns and Unknowns of Influenza B Viruses

Koutsakos, M., Nguyen, T. H. O., Barclay, W., & Kedzierska, K. (2015) · Future Microbiology · doi:10.2217/fmb.15.120 · Cited by 126

Emerging Influenza D Virus Threat: What We Know so Far!

Asha, K., & Kumar, B. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8020192 · Cited by 128

Evolutionary characteristics of influenza B virus since its first isolation in 1940: dynamic circulation of deletion and insertion mechanism

Nerome, R., Hiromoto, Y., Sugita, S., Tanabe, N., Ishida, M., Matsumoto, M., Lindstrom, S., Takahashi, T., & Nerome, K. (1998) · Archives of Virology · doi:10.1007/s007050050399 · Cited by 128

Universal Influenza B Virus Genomic Amplification Facilitates Sequencing, Diagnostics, and Reverse Genetics

Zhou, B., Lin, X., Wang, W., Halpin, R., Bera, J., Stockwell, T. B., Barr, I., & Wentworth, D. E. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03265-13 · Cited by 126

An overview of the regulation of influenza vaccines in the United States

Weir, J. P., & Gruber, M. F. (2016) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12383 · Cited by 122

Prevention of Symptomatic Seasonal Influenza in 2005–2006 by Inactivated and Live Attenuated Vaccines

Ohmit, S. E., Victor, J. C., Teich, E., Truscon, R., Rotthoff, J. R., Newton, D. W., Campbell, S. A., Boulton, M. L., & Monto, A. S. (2008) · The Journal of Infectious Diseases · doi:10.1086/589885 · Cited by 121

Antigenic and Genetic Characterization of the Haemagglutinins of Recent Cocirculating Strains of Influenza B Virus

Rota, P. A., Hemphill, M. L., Whistler, T., Regnery, H. L., & Kendal, A. P. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-10-2737 · Cited by 118

65 years of influenza surveillance by a World Health Organization‐coordinated global network

Ziegler, T. T., Mamahit, A., & Cox, N. J. (2018) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12570 · Cited by 121

The molecular epidemiology of influenza viruses

Cox, N. J., & Bender, C. A. (1995) · Seminars in Virology · doi:10.1016/s1044-5773(05)80013-7 · Cited by 115

Genome-wide evolutionary dynamics of influenza B viruses on a global scale

Langat, P., Raghwani, J., Dudas, G., Bowden, T. A., Edwards, S., Gall, A., Bedford, T., Rambaut, A., Daniels, R. S., Russell, C. A., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006749 · Cited by 114

Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity

Aguilar-Bretones, M., Fouchier, R. A. M., Koopmans, M., & van Nierop, G. P. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162192 · Cited by 108

Co-evolution of immunity and seasonal influenza viruses

Han, A. X., de Jong, S. P. J., & Russell, C. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00945-8 · Cited by 117

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

Kieninger, D. M., Sheldon, E. A., Lin, W., Yu, C., Bayas, J. M., Gabor, J. J., Esen, M., Roure, J. L. F., Pérez, S. N., Sanchez, C. A., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-343 · Cited by 105

Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir

Hurt, A. C., Barr, I., Härtel, G., & Hampson, A. W. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2003.11.008 · Cited by 104

Recent changes among human influenza viruses

Lin, Y. P., Gregory, V., Bennett, M., & Hay, A. J. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.011 · Cited by 104

Influenza B Viruses: Not to be Discounted

van de Sandt, C. E., Bodewes, R., Rimmelzwaan, G. F., & de Vries, R. D. (2015) · Future Microbiology · doi:10.2217/fmb.15.65 · Cited by 104

Burden of influenza B virus infection and considerations for clinical management

Zaraket, H., Hurt, A. C., Clinch, B., Barr, I., & Lee, N. L. S. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104970 · Cited by 100

Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults

Pépin, S., Donazzolo, Y., Jambrecina, A., Salamand, C., & Saville, M. K. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.08.069 · Cited by 99

Differentiation of Influenza B Virus Lineages Yamagata and Victoria by Real-Time PCR

Biere, B., Bauer, B., & Schweiger, B. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02116-09 · Cited by 99

The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies

Ambrose, C. S., Wu, X., Knuf, M., & Wutzler, P. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.11.104 · Cited by 97

Influenza A and B Virus Intertypic Reassortment through Compatible Viral Packaging Signals

Baker, S. F., Nogales, A., Finch, C. L., Tuffy, K. M., Domm, W., Perez, D. R., Topham, D. J., & Martínez‐Sobrido, L. (2014) · Journal of Virology · doi:10.1128/jvi.01440-14 · Cited by 97

Reassortment between Influenza B Lineages and the Emergence of a Coadapted PB1–PB2–HA Gene Complex

Dudas, G., Bedford, T., Lycett, S., & Rambaut, A. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu287 · Cited by 96

Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model

Ermler, M. E., Roubidoux, E. K., Sun, W., Hai, R., Amanat, F., Chromikova, V., Palese, P., & Krammer, F. (2017) · Journal of Virology · doi:10.1128/jvi.00286-17 · Cited by 90

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin

Liu, Y., Tan, H., Koutsakos, M., Jegaskanda, S., Esterbauer, R., Tilmanis, D., Aban, M., Kedzierska, K., Hurt, A. C., Kent, S. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08165-y · Cited by 88

Reassortment and evolution of current human influenza A and B viruses

Xu, X., Lindstrom, S., Shaw, M. W., Smith, C. B., Hall, H. E., Mungall, B. A., Subbarao, K., Cox, N. J., & Klimov, A. I. (2004) · Virus Research · doi:10.1016/j.virusres.2004.02.013 · Cited by 88

Heads, stalks and everything else: how can antibodies eradicate influenza as a human disease?

Neu, K. E., Henry, C., & Wilson, P. C. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2016.05.012 · Cited by 87

Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice

Asthagiri Arunkumar, G., Ioannou, A., Wohlbold, T. J., Meade, P., Aslam, S., Amanat, F., Ayllon, J., García-Sastre, A., & Krammer, F. (2019) · Journal of Virology · doi:10.1128/jvi.01696-18 · Cited by 80

Influenza Virus Resistance to Antiviral Therapy

van der Vries, E., Schutten, M., Fraaij, P. L. A., Boucher, C. A., & Osterhaus, A. D. M. E. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-405880-4.00006-8 · Cited by 84

Variation in Influenza B Virus Epidemiology by Lineage, China

Yang, J., Lau, Y. C., Wu, P., Feng, S., Wang, X., Chen, T., Ali, S. T., Peng, Z., Fang, V. J., Zhang, J., et al. (2018) · Emerging infectious diseases · doi:10.3201/eid2408.180063 · Cited by 84

Live Attenuated Influenza Vaccine

Jin, H., & Subbarao, K. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_410 · Cited by 84

Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective

Madsen, A., Dai, Y.-N., McMahon, M., Schmitz, A. J., Turner, J. S., Tan, J., Lei, T., Alsoussi, W. B., Strohmeier, S., Amor, M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.015 · Cited by 81

The continual threat of influenza virus infections at the human–animal interface

Bailey, E. S., Choi, J. Y., Fieldhouse, J. K., Borkenhagen, L. K., Zemke, J. N., Zhang, D., & Gray, G. C. (2018) · Evolution Medicine and Public Health · doi:10.1093/emph/eoy013 · Cited by 80

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

Beran, J., Wertzova, V., Honegr, K., Kaliskova, E., Havlíčková, M., Havlík, J., Jiřincová, H., Belle, P. V., Jain, V., Innis, B. L., et al. (2009) · BMC Infectious Diseases · doi:10.1186/1471-2334-9-2 · Cited by 80

WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: Epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011

Klimov, A. I., Garten, R. J., Russell, C. A., Barr, I., Besselaar, T. G., Daniels, R. S., Engelhardt, O. G., Grohmann, G. S., Itamura, S., Kelso, A., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.07.089 · Cited by 79

Genomic nucleotide sequence of a foot-and-mouth disease virus clone and its persistent derivatives

Toja, M., Escarmı́s, C., & Domingo, E. (1999) · Virus Research · doi:10.1016/s0168-1702(99)00089-1 · Cited by 79

Immunogenicity and Safety of a Quadrivalent Live Attenuated Influenza Vaccine in Children

Block, S. L., Falloon, J., Hirschfield, J. A., Krilov, L. R., Dubovsky, F., Yi, T., & Belshe, R. B. (2012) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31825687b0 · Cited by 78

Universal Influenza B Vaccine Based on the Maturational Cleavage Site of the Hemagglutinin Precursor

Bianchi, E., Liang, X., Ingallinella, P., Finotto, M., Chastain, M. A., Fan, J., Fu, T., Song, H. C., Horton, M. S., Freed, D. C., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7380-7388.2005 · Cited by 76

Molecular studies of influenza B virus in the reverse genetics era

Jackson, D., Elderfield, R. A., & Barclay, W. (2010) · Journal of General Virology · doi:10.1099/vir.0.026187-0 · Cited by 75

Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden.

Tisa, V., Barberis, I., Faccio, V., Paganino, C., Trucchi, C., Martini, M., & Ansaldi, F. (2016) · PubMed Central · Cited by 75

Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination

Abreu, R. B., Kirchenbaum, G. A., Clutter, E. F., Sautto, G. A., & Ross, T. M. (2019) · JCI Insight · doi:10.1172/jci.insight.132155 · Cited by 71

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia‐Pacific region

Jennings, L., Huang, Q. S., Barr, I., Lee, P., Kim, W. J., Buchy, P., Sanicas, M., Mungall, B. A., & Chen, J. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12522 · Cited by 72

Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach

Sun, W., Roubidoux, E. K., Ermler, M. E., Nachbagauer, R., Broecker, F., Krammer, F., & Palese, P. (2019) · Journal of Virology · doi:10.1128/jvi.00333-19 · Cited by 70

Imprinting, immunodominance, and other impediments to generating broad influenza immunity

Knight, M., Changrob, S., Li, L., & Wilson, P. C. (2020) · Immunological Reviews · doi:10.1111/imr.12900 · Cited by 69

Structural basis for the divergent evolution of influenza B virus hemagglutinin

Ni, F., Kondrashkina, E., & Wang, Q. (2013) · Virology · doi:10.1016/j.virol.2013.07.035 · Cited by 67

Influenza B Viruses Exhibit Lower Within-Host Diversity than Influenza A Viruses in Human Hosts

Valesano, A. L., Fitzsimmons, W. J., McCrone, J. T., Petrie, J. G., Monto, A. S., Martin, E. T., & Lauring, A. S. (2019) · Journal of Virology · doi:10.1128/jvi.01710-19 · Cited by 67

Differing Epidemiological Dynamics of Influenza B Virus Lineages in Guangzhou, Southern China, 2009-2010

Tan, Y., Guan, W., Lam, T. T., Pan, S.-H., Wu, S., Zhan, Y., Viboud, C. G., Holmes, E. C., & Yang, Z. (2013) · Journal of Virology · doi:10.1128/jvi.01039-13 · Cited by 67

Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children

Langley, J. M., Martínez, A. C., Chatterjee, A., Halperin, S. A., McNeil, S., Reisinger, K. S., Aggarwal, N., Huang, L., Peng, C., García-Sicilia, J., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit263 · Cited by 67

Efficacy, immunogenicity, and safety evaluation of an MF59-adjuvanted quadrivalent influenza virus vaccine compared with non-adjuvanted influenza vaccine in children: a multicentre, randomised controlled, observer-blinded, phase 3 trial

Vesikari, T., Kirstein, J. L., Gomez-Go, G. D., Leav, B. A., Ruzycky, M. E., Isakov, L., de Bruijn, M., Oberyé, J., & Heijnen, E. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30108-5 · Cited by 67

Influenza virus N-linked glycosylation and innate immunity

York, I. A., Stevens, J., & Alymova, I. V. (2018) · Bioscience Reports · doi:10.1042/bsr20171505 · Cited by 67

Report of a Workshop on Respiratory Viral Infections: Epidemiology, Diagnosis, Treatment, and Prevention

McIntosh, K., Halonen, P. E., & Ruuskanen, O. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/16.1.151 · Cited by 67

Evidence for Viral Interference and Cross-reactive Protective Immunity Between Influenza B Virus Lineages

Laurie, K., Horman, W. S. J., Carolan, L. A., Chan, K. F., Layton, D., Bean, A. G. D., Vijaykrishna, D., Reading, P. C., McCaw, J. M., & Barr, I. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix509 · Cited by 66

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults

Beran, J., Peeters, M., Dewé, W., Raupachová, J., Hobzová, L., & Devaster, J. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-224 · Cited by 65

The prospects and challenges of universal vaccines for influenza

Subbarao, K., & Matsuoka, Y. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.04.003 · Cited by 64

A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults

Block, S. L., Yi, T., Sheldon, E. A., Dubovsky, F., & Falloon, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.109 · Cited by 64

The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

Janssens, Y., Joye, J., Waerlop, G., Clément, F., Leroux-Roels, G. G., & Leroux‐Roels, I. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.959379 · Cited by 62

Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/Yamagata

Skowronski, D. M., Salway, T. J., Serres, G. D., Ward, B. J., Janjua, N. Z., Sabaiduc, S., Chan, T., & Petric, M. (2011) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31822db4dc · Cited by 63

Evolution of influenza B/Victoria/2/87-like viruses: occurrence of a genetically conserved virus under conditions of low epidemic activity

Kinnunen, L., Ikonen, N., Pöyry, T. A. A., & Pyhälä, R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-3-733 · Cited by 23

Antigenic and Genetic Characterization of the Haemagglutinins of Recent Cocirculating Strains of Influenza B Virus

Rota, P. A., Hemphill, M. L., Whistler, T., Regnery, H. L., & Kendal, A. P. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-10-2737 · Cited by 118

Antigenic and genetic analyses of influenza type B viruses isolated in Russia, 1987–91

Hemphill, M. L., Rota, P. A., Иванова, В. Т., Slepushkin, A. N., & Kendal, A. P. (1993) · Epidemiology and Infection · doi:10.1017/s0950268800057265 · Cited by 7

Recent influenza B viruses in Europe: a phylogenetic analysis

Ikonen, N., Kinnunen, L., Forsten, T., & Pyhälä, R. (1996) · Clinical and Diagnostic Virology · doi:10.1016/0928-0197(96)00201-2 · Cited by 11

Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season

Kanegae, Y., Sugita, S., Endo, A., Ishida, M., Senya, S., Osako, K., Nerome, K., & Oya, A. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.2860-2865.1990 · Cited by 176